Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx (NASDAQ:GDRX) and its peers. Healthcare technology companies develop software, ...

The author suggests three ways Congress should act to make life-altering medications affordable for Americans.

With after-Christmas sales underway and President’s Day deals just around the corner, it’s easy to buy something only to see ...

Consumer Reports said overpaying happens more often than many shoppers realize, but knowing a store's pricing policies can ...

GoodRx reports five major changes to Medicare in 2026, including a $2,100 Part D out-of-pocket limit, prior authorization for ...

Modeling from the Washington think tank finds that tariffs imposed by the current Trump administration amount to an average ...

Start by asking about generics Generic medications offer the same quality, safety and effectiveness as brand-name drugs but ...

The FDA has approved Novo Nordisk’s oral Wegovy, marking the first pill-form GLP-1 drug for chronic weight management in the ...

Additionally, Morgan Stanley reduced its price target for GoodRx from $5 to $4 while maintaining an Equal Weight rating on December 18. In a 2026 outlook for the Healthcare Services sector, the firm ...

Consumers can soon go to GoodRx (GDRX) for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation “We’re excited to help consumers access one of ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is ...